-+ 0.00%
-+ 0.00%
-+ 0.00%

INCYTE: EXPECTS TO FILE A SBLA FOR TAFASITAMAB FOR FIRST-LINE TREATMENT OF ADULTS WITH NEWLY DIAGNOSED DLBCL IN H1 2026

路透·01/05/2026 12:30:00

登錄查看新聞詳情